Name: 글로벌 시장 동향
SKU: CD2081
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 등온 핵산 증폭 기술 시장은 2022년 33억 달러 규모에 달했으며, 2030년까지 75억 달러에 이르러 높은 성장세를 보일 것으로 예상됩니다. 등온 핵산 증폭 기술 시장은 2023년부터 2030년까지 연평균 11.1%의 성장률을 기록할 것으로 전망됩니다.
등온 핵산 증폭은 일정한 온도에서 핵산 서열을 빠르고 효율적으로 수집하는 기술입니다. 핵산 증폭 기술은 분자 생물학 및 재조합 DNA 연구에 활용됩니다. 이러한 방법은 소량의 핵산을 식별하고 분석하는 데 있어 핵심적인 기술로 사용됩니다.
시장 동향
전 세계적으로 증가하는 감염성 질환이 예측 기간 동안 전 세계 등온 핵산 증폭 기술 시장 성장을 견인하고 있습니다.

전 세계적으로 증가하는 감염성 질환은 예측 기간 동안 전 세계 등온 핵산 증폭 기술(INAAT) 시장의 성장을 촉진하는 주요 요인입니다. 예를 들어, 세계보건기구(WHO)는 2022년 10월 24일부터 2022년 11월 23일 사이에 5,000명 이상의 새로운 원숭이두창 환자를 등록했습니다. 또한, 2021년 말 기준으로 미국 질병통제예방센터(CDC)의 에이즈 대응 긴급 계획(PEPFAR)을 통한 HIV 치료 지원 결과, 1,170만 명 이상이 항레트로바이러스 치료(ART)를 받고 있었습니다.
증가하는 고령 인구는 전 세계 등온 핵산 증폭 기술 시장에 유망한 성장 기회를 제공하고 있습니다.
증가하는 고령 인구는 향후 몇 년 동안 전 세계 등온 핵산 증폭 시장에 유망한 성장 기회를 제공하고 있습니다. 예를 들어, 유엔의 세계 인구 전망 2022에 따르면 80세 이상 인구는 2022년 1억 5,700만 명에서 2050년 4억 5,900만 명으로 세 배 증가할 것으로 예상됩니다.
COVID-19 영향 분석
COVID-19 분석에는 COVID-19 이전 시나리오, COVID-19 시나리오, COVID-19 이후 시나리오와 함께 가격 변동(팬데믹 기간 및 이후의 가격 변화를 COVID-19 이전 시나리오와 비교), 수요-공급 스펙트럼(거래 제한, 봉쇄 및 그로 인한 문제로 인한 수요와 공급의 변화), 정부 정책(정부 기관의 시장, 부문 또는 산업 활성화를 위한 정책), 제조업체 전략적 이니셔티브(제조업체가 COVID-19 문제를 완화하기 위해 취한 조치)가 포함됩니다.

러시아-우크라이나 전쟁 영향 분석
러시아의 공격 개시 이후 세계보건기구(WHO)가 의료 시설에 대한 703건의 공격을 기록하면서, 이 전쟁은 전 세계 등온 핵산 증폭(INA) 시장에 다소 부정적인 영향을 미쳤습니다. 더욱이, 러시아군이 이웃 국가인 우크라이나의 내륙으로 진격함에 따라, 일반적인 인플레이션과 별개로 알루미늄, 구리, 철강, 플라스틱과 같은 주요 원자재 가격이 상승하여 가전제품 가격 상승을 더욱 부추기고 있습니다. 하지만 전쟁 속에서도 우크라이나는 환자들에게 필수적인 의료 서비스를 지속적으로 제공하고 있습니다.
글로벌 경기 침체 영향 분석
의료 산업은 경기 침체의 영향을 완전히 피할 수는 없습니다. 과거 경기 침체기 동안 의료 기관들은 인력 감축과 고용 감소를 경험했습니다. 그럼에도 불구하고, 의료 산업은 필수적인 서비스라는 특성상 다른 산업 분야보다 상대적으로 잘 대처하는 편입니다. 그러나 인플레이션이 지속적으로 상승함에 따라 경기 침체의 위험은 시장을 위협하고 있습니다.
지난 2년간 선진국의 높은 인플레이션으로 인해 전반적인 물가가 급등하면서, 지속적인 경기 침체에 대한 우려가 커지고 있습니다. 누적적으로 악화되는 전반적인 구매 통제는 특히 성장하는 경제에 영향을 미칠 것으로 예상되며, 여러 면에서 도움이 될 것으로 여겨집니다.
인공지능 영향 분석
인공지능은 향후 몇 년 동안 전 세계 등온 핵산 증폭 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 인공지능(AI)과 사물인터넷(IoT) 기술의 결합(AIoT)은 2세기 전 최초의 상업용 제빙기 발명 이후 등온 핵산 증폭 분야에 가장 큰 변화를 가져올 수 있습니다.
세그먼트 분석
전 세계 등온 핵산 증폭 기술 시장은 제품 유형, 응용 분야, 기술 및 지역별로 세분화됩니다.
루프 매개 등온 증폭(LAMP) 기술 유형 세그먼트는 예측 기간 동안 시장에서 지배적인 위치를 차지할 것으로 예상됩니다.
루프 매개 등온 증폭(LAMP)은 시장에 출시되는 제품 증가로 인해 2030년까지 시장 점유율 28.6%를 차지할 것으로 예상됩니다. 예를 들어, 2022년 3월, 과학 기기, 시약 및 소모품, 소프트웨어 서비스를 제공하는 미국의 Thermo Fisher Scientific은 바이러스 병원체를 신속하고 저렴하게 식별하는 두 가지 새로운 역전사 루프 매개 등온 증폭(RT-LMA) 기반 기술을 발표했습니다.
지리적 분석
유럽은 예측 기간 동안 전 세계 등온 핵산 증폭 기술 시장에서 두 번째로 큰 점유율을 차지할 것으로 예상됩니다.
암 사망자 수 증가와 암 퇴치를 위한 노력 증대로 인해 유럽은 2030년까지 전 세계 등온 핵산 증폭 시장의 약 25.9%를 차지할 것으로 예상됩니다. 예를 들어, 2022년 Health at a Glance 보고서에 따르면 암은 심혈관 질환에 이어 EU에서 두 번째로 큰 사망 원인입니다.
암 환자 사망의 30~50%는 예방 가능하며, 조기 발견과 시의적절하고 효과적인 치료를 통해 사망률을 줄일 수 있습니다. 유럽의 암 퇴치 계획(Europe’s Beating Cancer Plan)은 회원국의 활동을 지원, 조정 및 보완함으로써 암 부담을 줄이고 국가 간 및 국가 내 암 관련 불균형을 해소하는 것을 목표로 합니다.
경쟁 환경
주요 글로벌 시장 참여 기업으로는 bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited, Thermo Fisher Scientific 등이 있습니다.
보고서 구매 이유

• 제품 유형, 응용 분야, 기술, 최종 사용자 및 지역별 글로벌 등온 핵산 증폭 기술 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악합니다.

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 등온 핵산 증폭 기술 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.
글로벌 등온 핵산 증폭 기술 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량입니다.
2023년 주요 고객층
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Isothermal Nucleic Acid Amplification Technology Market reached USD 3.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 7.5 billion by 2030. the isothermal nucleic acid amplification technology market is expected to exhibit a CAGR of 11.1% during the forecast period 2023-2030.
Isothermal nucleic acid amplification is a technique that quickly and effectively collects nucleic acid series at a consistent temperature. Nucleic acid amplification technologies are employed in molecular biology and recombinant DNA approaches. These methods are employed as top practices in identifying and investigating a short number of nucleic acids.
Market Dynamics
The Growing Prevalence of Infectious Diseases Globally is Driving the Global Isothermal Nucleic Acid Amplification Technology Market in the Forecast Period.
The growing prevalence of infectious diseases globally is driving the global isothermal nucleic acid amplification technology (INAAT) market growth during the forecast period. For instance, the World Health Organization registered over 5,000 fresh monkeypox patients between October 24, 2022 to November 23, 2022. Moreover, at the end of 2021, over 11.7 million individuals were on Anti Retroviral Treatment (ART) outcome of the CDC’s aid for HIV care and treatment via the U.S. President’s Emergency Plan for AIDS Response.
The Growing Geriatric Population is Providing the Global Isothermal Nucleic Acid Amplification Technology Market With Prospective Growth Opportunities.
The growing geriatric population is presenting the global isothermal nucleic acid amplification market with prospective growth opportunities in the upcoming years. For instance, according to the World Population Prospects 2022, from the UN, the number of individuals aged 80 or above is anticipated to grow triple fold, from 157 million in 2022 to 459 million by 2050.
COVID-19 Impact Analysis
The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).
Russia-Ukraine War Impact Analysis
The war has negatively impacted the global isothermal nucleic acid amplification market to a slight extent as the WHO has recorded 703 attacks on health infrastructure since Russia's attack started. Moreover, as Russian armed forces progress deeper into the heart of neighboring Ukraine, costs of key raw materials such as aluminum, copper, steel and plastic, separated from general inflation, are currently threatening additional cost escalation for white goods commodities. However, despite the War, Ukraine continues to provide necessary health services to patients.
Global Recession Impact Analysis
The healthcare industry is not completely immune to recession, as healthcare institutions thought firings and employment during past financial downturns. That stated, the industry does cope finer than other sectors because of its essential nature. However, the danger of recession threatens the market as inflation persists increasing.
The elevated extent of tension about the persistent recession as the high inflation in developed countries worldwide has transpired in a general cost surge over the past two years. The cumulatively deteriorating general purchasing control is anticipated to affect growing economies particularly and is considered helpful in numerous ways.
Artificial Intelligence Impact Analysis
Artificial intelligence is estimated to have a positive impact on the global isothermal nucleic acid amplification market in the upcoming years. The combination of artificial intelligence (AI) and Internet of Things (IoT) technology (AIoT) may be the biggest disruption to the isothermal nucleic acid amplification since the invention of the first commercial ice-making machine two centuries ago.
Segment Analysis
The global isothermal nucleic acid amplification technology market is segmented based on product type, applications, technology and region.
The Loop-mediated Isothermal Amplification (LAMP) Technology Type Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period.
Loop-mediated Isothermal Amplification (LAMP) is estimated to hold 28.6% of the market share by 2030 owing to the increasing product introductions into the market. For instance, in March 2022, Thermo fisher scientific, an American supplier of scientific instrumentation, reagents and consumables and software services, introduced two new reverse transcription loop-mediated isothermal amplification-based developments that deliver a rapid and inexpensive technique for identifying viral pathogens.
Geographical Analysis
Europe is Estimated to Hold the Second-largest Share of the Global Isothermal Nucleic Acid Amplification Technology Market During the Forecast Period.
Owing to the increasing number of cancer deaṭhs and growing efforts to fight against cancer Europe is estimated to hold around 25.9% of the global isothermal nucleic acid amplification market by 2030. For instance, according to the 2022 edition of Health at a Glance, cancer is the second greatest reason for death in the EU behind cardiovascular disorders.
Between 30‑50% of cancer patients' deaths are avoidable and mortality can also be reduced through earlier detection and the condition of better punctual and effective therapies. Europe’s Beating Cancer Plan strives to decrease the load of cancer and manage cancer-related imbalances between and within nations, with efforts to help, coordinate and complete the actions of Member States.
Competitive Landscape
The major global players in the market include bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited and Thermo Fisher Scientific among others.
Why Purchase the Report?
• To visualize the global isothermal nucleic acid amplification technology market segmentation based on product type, applications, technology, end user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of isothermal nucleic acid amplification technology market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The Global Isothermal Nucleic Acid Amplification Technology Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.
Target Audience 2023
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Applications
3.3. Snippet by Technology
3.4. Snippet by End User
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Demand for Isothermal Nucleic Acid Amplification Technology for Storage Purposes
4.1.1.2. Market Developments.
4.1.2. Restraints
4.1.2.1. The Growing Trend of Using Refurbished Equipment
4.1.3. Opportunity
4.1.4. Government Initiatives
4.1.5. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Regulatory Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. PEST Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario After COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Global Recession Analysis
9. Artificial Intelligence Impact Analysis
10. By Product Type
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.1.2. Market Attractiveness Index, By Product Type
10.2. Instruments
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Reagents
11. By Applications
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
11.1.2. Market Attractiveness Index, By Applications
11.2. Infectious Diseases Diagnostics*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Blood Screening
11.4. Cancer Research
11.5. Others
12. By Technology
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.1.2. Market Attractiveness Index, By Technology
12.2. Nucleic Acid Sequence-based Amplification (NASBA)
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Single Primer Isothermal Amplification (SPIA)
12.4. Nicking Enzyme Amplification Reaction (NEAR)
12.5. Helicase-dependent Amplification (HDA)
12.6. Transcription Mediated Amplification (TMA)
12.7. Loop-mediated Isothermal Amplification (LAMP)
12.8. Strand Displacement Amplification (SDA)
12.9. Others
13. By End User
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.1.2. Market Attractiveness Index, By End User
13.2. Hospitals and Clinics
13.2.1. Introduction
13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
13.3. Diagnostic Center
13.4. Research Laboratories
13.5. Others
14. By Region
14.1. Introduction
14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
14.1.2. Market Attractiveness Index, By Region
14.2. North America
14.2.1. Introduction
14.2.2. Key Region-Specific Dynamics
14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.2.7.1. The U.S.
14.2.7.2. Canada
14.2.7.3. Mexico
14.3. Europe
14.3.1. Introduction
14.3.2. Key Region-Specific Dynamics
14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.3.7.1. Germany
14.3.7.2. The U.K.
14.3.7.3. France
14.3.7.4. Italy
14.3.7.5. Spain
14.3.7.6. Rest of Europe
14.4. South America
14.4.1. Introduction
14.4.2. Key Region-Specific Dynamics
14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.4.7.1. Brazil
14.4.7.2. Argentina
14.4.7.3. Rest of South America
14.5. Asia-Pacific
14.5.1. Introduction
14.5.2. Key Region-Specific Dynamics
14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
14.5.7.1. China
14.5.7.2. India
14.5.7.3. Japan
14.5.7.4. Australia
14.5.7.5. Rest of Asia-Pacific
14.6. Middle East and Africa
14.6.1. Introduction
14.6.2. Key Region-Specific Dynamics
14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Applications
14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
15. Competitive Landscape
15.1. Competitive Scenario
15.2. Market Share Analysis
15.3. Mergers and Acquisitions Analysis
16. Company Profiles
16.1. Thermo Fisher Scientific Inc.
16.1.1. Company Overview
16.1.2. Product Type Portfolio and Description
16.1.3. Financial Overview
16.1.4. Key Developments
16.2. bioMerieux
16.3. Becton, Dickinson & Company
16.4. Lucigen
16.5. Qiagen
16.6. Quidel Corporation
16.7. Eiken Chemical Co. Ltd
16.8. Tecan Genomics Inc.
16.9. Meridian Bioscience
16.10. OptiGene Limited
LIST NOT EXHAUSTIVE
17. Appendix
17.1. About Us and Services
17.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific Inc., 4.	Key Developments, bioMerieux, Becton, Dickinson & Company, Lucigen, Qiagen, Quidel Corporation, Eiken Chemical Co. Ltd, Tecan Genomics Inc., Meridian Bioscience, OptiGene Limited

표 목록 (Tables)

List of Tables

Table 1 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2022, 2026 & 2030 (USD Million)

Table 2 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2022, 2026 & 2030 (USD Million)

Table 3 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2022, 2026 & 2030 (USD Million)

Table 4 Global Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2022, 2026 & 2030 (USD Million)

Table 5 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Region, 2022, 2026 & 2030 (USD Million)

Table 6 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2022, 2026 & 2030 (USD Million)

Table 7 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2021-2030 (USD Million)

Table 8 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2022, 2026 & 2030 (USD Million)

Table 9 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2021-2030 (USD Million)

Table 10 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2022, 2026 & 2030 (USD Million)

Table 11 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2021-2030 (USD Million)

Table 12 Global Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2022, 2026 & 2030 (USD Million)

Table 13 Global Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2021-2030 (USD Million)

Table 14 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Region, 2022, 2026 & 2030 (USD Million)

Table 15 Global Isothermal Nucleic Acid Amplification Technology Market Value, By Region, 2021-2030 (USD Million)

Table 16 North America Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2021-2030 (USD Million)

Table 17 North America Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2021-2030 (USD Million)

Table 18 North America Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2021-2030 (USD Million)

Table 19 North America Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2021-2030 (USD Million)

Table 20 North America Isothermal Nucleic Acid Amplification Technology Market Value, By Country, 2021-2030 (USD Million)

Table 21 South America Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2021-2030 (USD Million)

Table 22 South America Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2021-2030 (USD Million)

Table 23 South America Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2021-2030 (USD Million)

Table 24 South America Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2021-2030 (USD Million)

Table 25 South America Isothermal Nucleic Acid Amplification Technology Market Value, By Country, 2021-2030 (USD Million)

Table 26 Europe Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2021-2030 (USD Million)

Table 27 Europe Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2021-2030 (USD Million)

Table 28 Europe Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2021-2030 (USD Million)

Table 29 Europe Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2021-2030 (USD Million)

Table 30 Europe Isothermal Nucleic Acid Amplification Technology Market Value, By Country, 2021-2030 (USD Million)

Table 31 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2021-2030 (USD Million)

Table 32 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2021-2030 (USD Million)

Table 33 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2021-2030 (USD Million)

Table 34 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2021-2030 (USD Million)

Table 35 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Value, By Country, 2021-2030 (USD Million)

Table 36 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Value, By Product Type, 2021-2030 (USD Million)

Table 37 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Value, By Applications, 2021-2030 (USD Million)

Table 38 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Value, By Technology, 2021-2030 (USD Million)

Table 39 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Value, By End User, 2021-2030 (USD Million)

Table 40 Thermo Fisher Scientific: Overview

Table 41 Thermo Fisher Scientific: Product Portfolio

Table 42 Thermo Fisher Scientific: Key Developments

Table 43 bioMerieux: Overview

Table 44 bioMerieux: Product Portfolio

Table 45 bioMerieux: Key Developments

Table 46 Becton, Dickinson & Company: Overview

Table 47 Becton, Dickinson & Company: Product Portfolio

Table 48 Becton, Dickinson & Company: Key Developments

Table 49 Lucigen: Overview

Table 50 Lucigen: Product Portfolio

Table 51 Lucigen: Key Developments

Table 52 Qiagen: Overview

Table 53 Qiagen: Product Portfolio

Table 54 Qiagen: Key Developments

Table 55 Quidel Corporation: Overview

Table 56 Quidel Corporation: Product Portfolio

Table 57 Quidel Corporation: Key Developments

Table 58 Eiken Chemical Co. Ltd: Overview

Table 59 Eiken Chemical Co. Ltd: Product Portfolio

Table 60 Eiken Chemical Co. Ltd: Key Developments

Table 61 Tecan Genomics Inc.: Overview

Table 62 Tecan Genomics Inc.: Product Portfolio

Table 63 Tecan Genomics Inc.: Key Developments

Table 64 Meridian Bioscience: Overview

Table 65 Meridian Bioscience: Product Portfolio

Table 66 Meridian Bioscience: Key Developments

Table 67 OptiGene Limited: Overview

Table 68 OptiGene Limited: Product Portfolio

Table 69 OptiGene Limited: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 2 Global Isothermal Nucleic Acid Amplification Technology Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Isothermal Nucleic Acid Amplification Technology Market Share, By Applications, 2022 & 2030 (%)

Figure 4 Global Isothermal Nucleic Acid Amplification Technology Market Share, By Technology, 2022 & 2030 (%)

Figure 5 Global Isothermal Nucleic Acid Amplification Technology Market Share, By End User, 2022 & 2030 (%)

Figure 6 Global Isothermal Nucleic Acid Amplification Technology Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Isothermal Nucleic Acid Amplification Technology Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Instruments Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 9 Reagents Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 10 Global Isothermal Nucleic Acid Amplification Technology Market Y-o-Y Growth, By Applications, 2022-2030 (%)

Figure 11 Infectious Diseases Diagnostics Applications in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 12 Blood Screening Applications in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 13 Cancer Research Applications in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 14 Other Applications in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 15 Global Isothermal Nucleic Acid Amplification Technology Market Y-o-Y Growth, By Technology, 2022-2030 (%)

Figure 16 Nucleic Acid Sequence-based Amplification (NASBA) Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 17 Single Primer Isothermal Amplification (SPIA) Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 18 Nicking Enzyme Amplification Reaction (NEAR) Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 19 Helicase-dependent Amplification (HDA) Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 20 Transcription Mediated Amplification (TMA) Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 21 Loop-mediated Isothermal Amplification (LAMP) Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 22 Strand Displacement Amplification (SDA) Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 23 Others Technology in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 24 Global Isothermal Nucleic Acid Amplification Technology Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 25 Hospitals and Clinics End User in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 26 Diagnostic Center End User in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 27 Research Laboratories End User in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 28 Other End Users in Global Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 29 Global Isothermal Nucleic Acid Amplification Technology Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 30 North America Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 31 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 32 Europe Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 33 South America Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 34 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 35 North America Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 36 North America Isothermal Nucleic Acid Amplification Technology Market Share, By Product Type, 2022 & 2030 (%)

Figure 37 North America Isothermal Nucleic Acid Amplification Technology Market Share, By Applications, 2022 & 2030 (%)

Figure 38 North America Isothermal Nucleic Acid Amplification Technology Market Share, By Technology, 2022 & 2030 (%)

Figure 39 North America Isothermal Nucleic Acid Amplification Technology Market Share, By End User, 2022 & 2030 (%)

Figure 40 North America Isothermal Nucleic Acid Amplification Technology Market Share, By Country, 2022 & 2030 (%)

Figure 41 South America Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 42 South America Isothermal Nucleic Acid Amplification Technology Market Share, By Product Type, 2022 & 2030 (%)

Figure 43 South America Isothermal Nucleic Acid Amplification Technology Market Share, By Applications, 2022 & 2030 (%)

Figure 44 South America Isothermal Nucleic Acid Amplification Technology Market Share, By Technology, 2022 & 2030 (%)

Figure 45 South America Isothermal Nucleic Acid Amplification Technology Market Share, By End User, 2022 & 2030 (%)

Figure 46 South America Isothermal Nucleic Acid Amplification Technology Market Share, By Country, 2022 & 2030 (%)

Figure 47 Europe Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 48 Europe Isothermal Nucleic Acid Amplification Technology Market Share, By Product Type, 2022 & 2030 (%)

Figure 49 Europe Isothermal Nucleic Acid Amplification Technology Market Share, By Applications, 2022 & 2030 (%)

Figure 50 Europe Isothermal Nucleic Acid Amplification Technology Market Share, By Technology, 2022 & 2030 (%)

Figure 51 Europe Isothermal Nucleic Acid Amplification Technology Market Share, By End User, 2022 & 2030 (%)

Figure 52 Europe Isothermal Nucleic Acid Amplification Technology Market Share, By Country, 2022 & 2030 (%)

Figure 53 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 54 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Share, By Product Type, 2022 & 2030 (%)

Figure 55 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Share, By Applications, 2022 & 2030 (%)

Figure 56 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Share, By Technology, 2022 & 2030 (%)

Figure 57 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Share, By End User, 2022 & 2030 (%)

Figure 58 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Market Share, By Country, 2022 & 2030 (%)

Figure 59 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Value, 2021-2030 (USD Million)

Figure 60 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Share, By Product Type, 2022 & 2030 (%)

Figure 61 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Share, By Applications, 2022 & 2030 (%)

Figure 62 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Share, By Technology, 2022 & 2030 (%)

Figure 63 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Share, By End User, 2022 & 2030 (%)

Figure 64 Thermo Fisher Scientific: Financials

Figure 65 bioMerieux: Financials

Figure 66 Becton, Dickinson & Company: Financials

Figure 67 Lucigen: Financials

Figure 68 Qiagen: Financials

Figure 69 Quidel Corporation: Financials

Figure 70 Eiken Chemical Co. Ltd: Financials

Figure 71 Tecan Genomics Inc.: Financials

Figure 72 Meridian Bioscience: Financials

Figure 73 OptiGene Limited: Financials

글로벌 등온 핵산 증폭 기술 시장 – 2023-2030

Global Isothermal Nucleic Acid Amplification Technology Market - 2023-2030